Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.

[1]  K. Mireskandari,et al.  Pediatric Corneal Transplantation—Where Are We Heading? , 2017, Current Ophthalmology Reports.

[2]  F. Yu,et al.  Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency , 2016, Cornea.

[3]  Jessica B. Ciralsky,et al.  Boston Keratoprosthesis Type 1 in the Pediatric Population , 2016, Current Ophthalmology Reports.

[4]  J. Chodosh,et al.  Infections after keratoprosthesis , 2016, Current opinion in ophthalmology.

[5]  Borja Salvador-Culla,et al.  Keratoprosthesis: A Review of Recent Advances in the Field , 2016, Journal of functional biomaterials.

[6]  Megan A Rowlands,et al.  Keratoprosthesis in pediatric keratitis-icthyosiform-deafness syndrome. , 2016, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[7]  Young H. Kwon,et al.  Boston type 1 keratoprosthesis for primary congenital glaucoma , 2015, British Journal of Ophthalmology.

[8]  Mark I Rosenblatt,et al.  Boston Keratoprosthesis: Outcomes and Complications: A Report by the American Academy of Ophthalmology. , 2015, Ophthalmology.

[9]  M. Harissi-Dagher,et al.  The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure , 2015, British Journal of Ophthalmology.

[10]  J. Chodosh,et al.  Primary Implantation of Type I Boston Keratoprosthesis in Nonautoimmune Corneal Diseases , 2015, Cornea.

[11]  R. Pappuru,et al.  Endophthalmitis in Boston keratoprosthesis: case series and review of literature , 2015, International Ophthalmology.

[12]  M. Harissi-Dagher,et al.  Characteristics and management of patients with Boston type 1 keratoprosthesis explantation--the University of Montreal Hospital Center experience. , 2014, American journal of ophthalmology.

[13]  Beatriz Munoz,et al.  Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. , 2014, Ophthalmology.

[14]  M. Harissi-Dagher,et al.  Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal. , 2014, American journal of ophthalmology.

[15]  J. Parel,et al.  Streptococcal endophthalmitis in pediatric keratoprosthesis. , 2013, Ophthalmology.

[16]  N. Allemann,et al.  Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston Keratoprosthesis. , 2013, American journal of ophthalmology.

[17]  M. S. Cortina,et al.  Visual Outcomes of Boston Keratoprosthesis Implantation as the Primary Penetrating Corneal Procedure , 2012, Cornea.

[18]  F. Yu,et al.  International results with the Boston type I keratoprosthesis. , 2012, Ophthalmology.

[19]  P. Padmanabhan,et al.  Outcome of Boston Keratoprosthesis in a Developing Country—Importance of Patient Selection, Education, and Perioperative Care: The Indian Experience , 2012, Asia-Pacific journal of ophthalmology.

[20]  M. Belin,et al.  Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. , 2012, Ophthalmology.

[21]  E. Holland,et al.  Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. , 2012, American journal of ophthalmology.

[22]  M. Harissi-Dagher,et al.  Review of endophthalmitis following Boston keratoprosthesis type 1 , 2012, British Journal of Ophthalmology.

[23]  M. Mannis,et al.  Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. , 2011, Ophthalmology.

[24]  K. Colby,et al.  Expanding indications for the Boston keratoprosthesis , 2011, Current opinion in ophthalmology.

[25]  J. Chodosh,et al.  Expanding Application of the Boston Type I Keratoprosthesis Due to Advances in Design and Improved Post-operative Therapeutic Strategies , 2010, Seminars in ophthalmology.

[26]  K. Colby,et al.  Keratoprosthesis: Procedure of Choice for Corneal Opacities in Children? , 2010, Seminars in ophthalmology.

[27]  M. Klufas,et al.  The Boston Keratoprosthesis , 2010, International ophthalmology clinics.

[28]  E. Cohen,et al.  Boston Keratoprosthesis Outcomes and Complications , 2009, Cornea.

[29]  M. Mannis,et al.  Primary Pediatric Keratoplasty: Indications and Outcomes , 2009, Cornea.

[30]  F. Yu,et al.  The Boston type I keratoprosthesis: improving outcomes and expanding indications. , 2009, Ophthalmology.

[31]  I. Schwab,et al.  Boston Type 1 Keratoprosthesis: The University of California Davis Experience , 2009, Cornea.

[32]  R. Pineda,et al.  Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. , 2007, American journal of ophthalmology.

[33]  G. Zaidman,et al.  Long-term visual prognosis in children after corneal transplant surgery for Peters anomaly type I. , 2007, American journal of ophthalmology.

[34]  M. Belin,et al.  Results from the multicenter Boston Type 1 Keratoprosthesis Study. , 2006, Ophthalmology.

[35]  N. Congdon,et al.  Keratoprosthesis in high-risk pediatric corneal transplantation: first 2 cases. , 2006, Archives of ophthalmology.

[36]  R. D. Stulting,et al.  Long-term results of corneal graft survival in infants and children with peters anomaly. , 1999, Ophthalmology.

[37]  S. Isenberg,et al.  Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects. , 1988, The British journal of ophthalmology.